Apolipoprotein E genotype and gender influence response to tacrine therapy

Annals of the New York Academy of Sciences

Volumn 802, Issue , 1996, Pages 101-110

  Farlow, Martin R ^a   Lahiri, Debomoy K ^a   Poirier, Judes ^b   Davignon, Jean ^c   Hui, Siu ^a  

^a INDIANA UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLINESTERASE INHIBITOR; TACRINE;

ADULT; ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 0030476825     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb32603.x     Document Type: Conference Paper

References (25)

1. PERRY, E. K., R. H. PERRY, G. BLESSED & B. E. TOMLINSON. 1977. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neurosci Lett. 6: 85-89.
2. WHITEHOUSE, P. J., D. L. PRICE, R. G. STRUBLE, A. W. CLARK & J. COYLE. 1981. Alzheimer's disease and senile dementia: A loss of neurons in the basal forebrain. Science 215: 1237-1239.
3. HEFTI, F. & L. S. SCHNEIDER. 1989. Rationale for the planned clinical trials with nerve growth factor in Alzheimer's disease. Psychiatr. Dev. 7: 297-315.
4. SCHNEIDER, L. S. & M. R. FARLOW. 1995. Predicting response to cholinesterase inhibitors in Alzheimer's disease. Possible approaches. CNS Drugs 4(2): 114-124.
5. FARLOW, M. R., S. I. GRACON, L. A. HERSHEY, K. W. LEWIS, C. H. SADOWSKY & J. DOLAN-URENO, for the Tacrine Study Group. 1992. A controlled trial of tacrine in Alzheimer's disease. J. Am. Med. Assoc. 268: 2523-2529.
6. POIRIER, J., A. BACCICHET, D. DEA & S. GALTHIER. 1993. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55: 81-90.
7. SAUNDERS, A. M., W. J. STRITTMATTER, D. SCHMECHEL, P. H. ST. GEORGE-HYSLOP, M. A. PERICAK-VANCE, S. H. JOO, B. L. ROSI, J. F. GUSELLA, D. R. CRAPPER-MACLACLAN, M. J. ALBERTS, C. HULETTE, B. CRAIN, D. GOLDGABER & A. D. ROSES. 1993. Association of apolipoprotein E allele E4 with late onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
8. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL, G. W. SMALL, A. D. ROSES, J. L. HAINES & M. A. PERICAK-VANCE. 1993. Gene dose of apolipoprotein E type 4 allele and risk of Alzheimer's disease in late onset families. Science 261: 921-923.
9. PAYAMI, H., J. KAYE, L. L. HESTON, T. D. BIRD & G. D. SCHELLENBERG. 1993. Apolipoprotein E and Alzheimer's disease. Lancet 342: 738.
10. POIRIER, J. 1994. Apolipoprotein E in animal models of brain injury and in Alzheimer's disease. Trends Neurosci. 12: 525-530.
11. KNAPP, M. J., D. S. KNOPMAN, P. R. SOLOMON, W. W. PENDLEBURY, C. S. DAVIS & S. I. GRACON; for the TACRINE STUDY GROUP. 1994. A 30-week randomized controlled clinical trial of high-dose tacrine in patients with Alzheimer's disease. J. Am. Med. Assoc. 271: 985-991.
12. MCKHANN, G., D. DRACHMAN, M. FOLSTEIN, R. KATZMAN, D. PRICE & E. M. STADLAN. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
13. FOLSTEIN, M. F., S. E. FOLSTEIN & P. R. MCHUGH. 1975. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12: 189-198.
14. POIRIER, J., J. DAVIGNON, D. BOUTHILLIER, S. KOGAN, P. BERTRAND & S. GAUTHIER. 1993. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342: 697-699.
15. ROSEN, W. G., R. C. MOHS & K. L. DAVIS. 1984. A new rating scale for Alzheimer's disease. Am. J. Psychiatry 141: 1356-1464.
16. REISBERG, B. & S. H. FERRIS. 1994. CIBIC-Plus Interview Guide. Sandoz Pharmaceuticals, Inc. Teaneck, NJ.
17. Clinical Global Assessment Scale (CGIC). 1976. In ECDEU Assessment Manual for Psychopharmacology. W. Guy, Ed. 218-222. US Dept of Health Education and Welfare, National Institute of Mental Health. Rockville, MD.
18. FRIZONI, G. B., S. GOVONI, C. GEROLDI, A. BIANCHETTI, L. CALABRESI, G. FRANCESCHINI, & M. TRABUCCHI. 1995. Gene dose of the ∈4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 37: 596-604.
19. PETERSEN, R. C., G. E. SMITH, R. J. IVNIK, E. G. TANGALOS, O. J. SCHAID, S. N. THIBODEAN, E. KOKMEN, S. G. WARING & L. T. KURKLAND. 1995. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory impaired individuals. J. Am. Med. Assoc. 273: 1274-1278.
20. POIRIER, J., M.-C. DELISLE, R. QUIRION, I. AUBERT, M. FARLOW, D. LAHIRI, S. HUI, P. BERTRAND, J. NALBANTOGLU & B. M. GILFIX. 1995. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc. Natl. Acad. Sci. USA 92: 12260-12264.
21. FARRER, L. A., L. A. CUPPLES, C. M. VAN DUIJN, A. KURZ, R. ZIMMER, U. MÜLLER, R. C. GREEN, V. CLARKE, J. SHOFFNER, D. C. WALLACE, H. CHUI, S. D. FLANAGAN, R. DUARA, P. ST. GEORGE-HYSLOP, S. A. AUERBACH, L. VOLICER, J. M. WELLS, C. VAN BROECKHOVEN, J. H. GROWDON & J. L. HAINES 1995. Apolipoprotein E genotype in patients with Alzheimer's disease: Implications for the risk of dementia among relatives. Ann. Neurol. 38: 797-808.
22. PAYAMI, H., K. R. MONTEE, J. A. KAYE, T. D. BIRD, C. E. YU, E. M. WIJSMAN & G. D. SCHELLENBERG. 1994. Alzheimer's disease, apolipoprotein E4, and gender. J. Am. Med. Assoc. 271: 1316-1317.
23. CORDER, E. H., A. M. SAUNDERS, W. J. STRITTMATTER, D. E. SCHMECHEL, P. C. GASKELL JR., A. D. ROSES, M. A. PERICAK-VANCE, G. W. SMALL & J. L. HAINES. 1995 The apolipoprotein E E4 allele and sex-specific risk of Alzheimer's disease. J. Am. Med. Assoc. 273: 373-374.
24. HISAMA, F. M. & G. D. SCHELLENBERG. 1996. Progress in molecular genetic of Alzheimer's disease. Neuroscientist 2: 3-6.
25. VAN BROECKHOVENS, C., H. BACKHOVENS, M. CRUTS, J. J. MARTIN, R. CROOK, H. HOULDEN & J. HARDY. 1994. APOE genotype does not modulate the age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci. Lett. 169: 179-180.